Biblio Discovery — Demo Discovery Service

12 results for "Guoliang Pi"

Showing 1–12 · 0.17 seconds · RSS

  1. Journal Article

    Geriatric nutritional risk index as a predictor of prognosis in hematologic malignancies: a systematic review and meta-analysis

    Qiong Yu; Mengxing Tian; Guoliang Pi et al.

    Frontiers in Nutrition, Vol. 10 · 2023 · English · DOAJ Scopus

    ObjectiveRecent studies have reported inconsistent results regarding the association between geriatric nutritional risk index (GNRI) and clinical outcomes in patients with hematologic malignancies (HMs). We performed a meta-analysis to evaluate the effect of low GNRI on the overall survival (OS)…

  2. Journal Article

    METTL3 methylated KIF15 promotes nasopharyngeal carcinoma progression and radiation resistance by blocking ATG7-mediated autophagy through the activation of STAT3 pathway

    Siwei Li; Shuibin Wang; Lu Zhang et al.

    Translational Oncology, Vol. 51 · 2025 · English · DOAJ Scopus

    Background: Resistance to radiotherapy is a major component in the failure of nasopharyngeal carcinoma (NPC) treatment. Enhancing autophagy in nasopharyngeal carcinoma may increase its radiation sensitivity, making it critical to find autophagy-modulating targets. Methods: The level of KIF15 was…

  3. Journal Article

    Optimizing induction chemotherapy regimens for radiotherapy in patients with locoregionally advanced nasopharyngeal carcinoma

    Ying Li; Jianping Bi; Guoliang Pi et al.

    Cancer Medicine, Vol. 12 No. 8 · 2023 · English · DOAJ Scopus

    Abstract Background and Purpose The optimal number of cycles of induction chemotherapy (IC) in locoregionally advanced nasopharyngeal carcinoma (LANPC) remains unresolved. This study aimed to quantitatively assess the changes in gross tumor volumes (GTVs) and to select the most optimal number of IC…

  4. Journal Article

    Association of PD-L1 and HIF-1α Coexpression with Poor Prognosis in Hepatocellular Carcinoma

    Xiaomeng Dai; Guoliang Pi; Sheng-li Yang et al.

    Translational Oncology, Vol. 11 No. 2 · 2018 · English · DOAJ Scopus

    OBJECTIVE: To investigate the correlation between the expression of PD-L1 and HIF-1α in hepatocellular carcinoma (HCC) tissue and further analyze the association with clinical parameters and the prognostic value of coexpression in HCC patients. METHODS: We assessed the expression of PD-L1 and…

  5. Journal Article

    Meta-analysis and indirect treatment comparison of modified FOLFIRINOX and gemcitabine plus nab-paclitaxel as first-line chemotherapy in advanced pancreatic cancer

    Jiayuan Chen; Qingling Hua; Haihong Wang et al.

    BMC Cancer, Vol. 21 No. 1 · 2021 · English · DOAJ Scopus

    Abstract Background Modified FOLFIRINOX and gemcitabine plus nab-paclitaxel (GEM-NAB) have been recommended as first-line therapies for advanced pancreatic cancer (PC). Due to the lack of evidence to directly compare them, we conducted this network meta-analysis to indirectly compare the…

  6. Journal Article

    The CCL2-CCR2 axis in primary lung cancer and pulmonary metastasis: from molecular mechanisms to therapeutic potentials

    Yujie Huang; Jia Ma; JianPing Bi et al.

    Frontiers in Immunology, Vol. 17 · 2026 · English · DOAJ Scopus

    Lung cancer remains the leading cause of cancer-related mortality worldwide, with metastasis, therapeutic resistance, and an immunosuppressive TME representing major barriers to successful treatment. Among the chemokine signaling networks implicated in these processes, the CCL2–CCR2 axis has…

  7. Journal Article

    Validation and modification of staging Systems for Poorly Differentiated Pancreatic Neuroendocrine Carcinoma

    Haihong Wang; Zhenyu Lin; Guiling Li et al.

    BMC Cancer, Vol. 20 No. 1 · 2020 · English · DOAJ Scopus

    Abstract Background The American Joint Committee on Cancer (AJCC) and the European Neuroendocrine Tumor Society (ENETS) staging classifications are two broadly used systems for pancreatic neuroendocrine tumors. This study aims to identify the most accurate and useful tumor–node–metastasis (TNM)…

  8. Journal Article

    Neoadjuvant stereotactic body radiotherapy combined with chemotherapy and Ivonescimab for Chinese luminal-type breast cancer patients: study protocol for a single-arm, open-label, phase II trial

    Ying Li; Yujie Huang; Jun Shao et al.

    BMJ Open, Vol. 15 No. 9 · 2025 · English · DOAJ Scopus

    Introduction Immunotherapy combined with chemotherapy has shown potential in improving the pathological complete response (pCR) rate in luminal-type breast cancer. This study explores whether the addition of stereotactic body radiotherapy (SBRT) and the bispecific antibody AK112 (Ivonescimab)…

  9. Journal Article

    Efficacy and safety of ondansetron orally soluble pellicle for preventing moderate- to high-emetic risk chemotherapy-induced nausea and vomiting

    Lu Sun; Jia Ma; Yajuan Zhou et al.

    BMC Cancer, Vol. 25 No. 1 · 2025 · English · DOAJ Scopus

    Abstract Objective Ondansetron orally soluble pellicle can serve as an alternative option for preventing nausea and vomiting in patients who receive chemotherapy. However, there is a lack of clinical evidence regarding ondansetron. This study aimed to explore the efficacy and safety of ondansetron…

  10. Journal Article

    The Regulators Associated With N6-Methyladenosine in Lung Adenocarcinoma and Lung Squamous Cell Carcinoma Reveal New Clinical and Prognostic Markers

    Shuzhen Tan; Zesong Li; Kai Li et al.

    Frontiers in Cell and Developmental Biology, Vol. 9 · 2021 · English · DOAJ Scopus

    N6-methyladenosine (m6A) methylation is of significant importance in the initiation and progression of tumors, but how specific genes take effect in different lung cancers still needs to be explored. The aim of this study is to analyze the correlation between the m6A RNA methylation regulators and…

  11. Journal Article

    Guidelines for gut microbiota technology of the chinese anti-cancer association (2025 Edition)

    Qiang Wang; Zhi Guo; Qingming Wu et al.

    Holistic Integrative Oncology, Vol. 5 No. 1 · 2026 · English · DOAJ Scopus

    Abstract The gut microbiota (GM) has emerged as a key regulator of cancer development, therapeutic efficacy, and treatment-related toxicity. Despite rapid advances in sequencing technologies, the clinical application of GM analysis in oncology lacks standardized technical and interpretative…